Mario Capecchi

Last updated
Mario Capecchi
MarioCapecchiFotoThalerTamas.JPG
Capecchi at a conference in 2013
Born
Mario Ramberg Capecchi

(1937-10-06) October 6, 1937 (age 87)
Verona, Italy
NationalityItalian, American
Alma mater Antioch College
Harvard University
Known for Hox genes in knockout mice
Awards Kyoto Prize (1996)
Franklin Medal (1997)
Albert Lasker Award for Basic Medical Research (2001)
Massry Prize (2002)
Wolf Prize in Medicine (2002)
Nobel Prize in Physiology or Medicine (2007)
Scientific career
Fields Genetics
Institutions Harvard Medical School
University of Utah
Thesis On the Mechanism of Suppression and Polypeptide Chain Initiation  (1967)
Doctoral advisor James D. Watson
Website capecchi.genetics.utah.edu

Mario Ramberg Capecchi (born 6 October 1937) is an Italian-born molecular geneticist and a co-awardee of the 2007 Nobel Prize in Physiology or Medicine for discovering a method to create mice in which a specific gene is turned off, known as knockout mice. [1] [2] [3] [4] [5] [6] He shared the prize with Martin Evans and Oliver Smithies. [7] He is currently Distinguished Professor of Human Genetics and Biology at the University of Utah School of Medicine. [8] [9] [10] [11] [12]

Contents

Life

Mario Capecchi was born in Verona, Italy, as the only child of Luciano Capecchi and Lucy Ramberg, an Italian-born [13] daughter of American-born Impressionist painter Lucy Dodd Ramberg and German archaeologist Walter Ramberg. His parents weren't married, and due to the chaos in Europe caused by World War II, the story of his early life is remarkable, but the details are unclear. In 1941 he and his mother were living near Bolzano, about 160 miles north of his father in Reggio Emilia when his mother was arrested and deported for pamphleteering and belonging to an anti-Fascist group. [14] Prior to her arrest [15] she had made contingency plans by selling her belongings and giving the proceeds to a nearby peasant family to care for her child. However, it was not long before Mario ended up on the streets of Bolzano. [16] [17] In July 1942, a few months before his fifth birthday, Italian records suggest he was reunited with his father in Reggio Emilia, which Mario did confirm but stated that he stayed with his father for only for a few brief periods [18] and that he mostly lived on the streets until he was placed in an orphanage towards the end of the war.

Mario almost died of malnutrition. His mother survived the war in Germany (part of the reason the details of his early life are unclear is that she would never talk about her experiences), and when it ended she began a year-long search for him. She finally found him on his ninth birthday in a hospital bed in Reggio Emilia ill with a fever and subsisting on a daily bowl of chicory coffee and bread crust. She took him to Rome, where he had his first bath since he had left her care and where, with money sent by his uncle, Edward Ramberg, an American physicist at RCA, they made arrangements to depart to the United States. He and his mother moved to Pennsylvania to live at an "intentionally cooperative community" called Bryn Gweled, [19] which had been co-founded by his uncle. (Capecchi's other maternal uncle, Walter Ramberg, was also a prominent American physicist [20] ). He graduated from George School, a Quaker boarding school in Bucks County, Pennsylvania, in 1956. [15]

Capecchi received his Bachelor of Science in chemistry and physics in 1961 from Antioch College in Ohio. Capecchi came to MIT as a graduate student intending to study physics and mathematics, [21] but during the course of his studies, he became interested in molecular biology. His change of interest was driven by the preference of working with few scientists and conducting experiments that did not require the use of big machines. He subsequently transferred to Harvard to join the lab of James D. Watson, co-discoverer of the structure of DNA. [22] Capecchi received his PhD in biophysics in 1967 [23] from Harvard University, with his doctoral thesis completed under the tutelage of Watson.

Capecchi was a Junior Fellow of the Society of Fellows at Harvard University from 1967 to 1969. In 1969 he became an assistant professor in the Department of Biochemistry at Harvard Medical School. He was promoted to associate professor in 1971. In 1973 he joined the faculty at the University of Utah. Since 1988 Capecchi has also been an investigator of the Howard Hughes Medical Institute. He is a member of the National Academy of Sciences. He has given a talk for Duke University's Program in Genetics and Genomics as part of their Distinguished Lecturer Series. [24] He was the speaker for the 2010 Racker Lectures in Biology & Medicine and Cornell Distinguished Lecture in Cell and Molecular Biology at Cornell University. [25] He is a member of the Italy-USA Foundation.

After the Nobel committee publicly announced that Capecchi was awarded the Nobel prize, an Austrian woman named Marlene Bonelli claimed that Capecchi was her long-lost half-brother. [26] In May 2008, Capecchi met with Bonelli, then 69, in northern Italy, and confirmed that she was his sister. [27]

Knockout mice

Capecchi was awarded the Nobel prize for creating a knockout mouse. This is a mouse, created by genetic engineering and in vitro fertilization, in which a particular gene has been turned off. [28] For this work, Capecchi was awarded the 2007 Nobel prize for medicine or physiology, along with Martin Evans and Oliver Smithies, who also contributed.

Capecchi has also pursued a systematic analysis of the mouse Hox gene family. This gene family plays a key role in the control of embryonic development in all multicellular animals. They determine the placement of cellular development in the proper order along the axis of the body from head to toe.

Honours

Related Research Articles

Howard Robert Horvitz ForMemRS NAS AAA&S APS NAM is an American biologist whose research on the nematode worm Caenorhabditis elegans was awarded the 2002 Nobel Prize in Physiology or Medicine, together with Sydney Brenner and John E. Sulston, whose "seminal discoveries concerning the genetic regulation of organ development and programmed cell death" were "important for medical research and have shed new light on the pathogenesis of many diseases".

<span class="mw-page-title-main">Richard Axel</span> American molecular biologist

Richard Axel is an American molecular biologist and university professor in the Department of Neuroscience at Columbia University and investigator at the Howard Hughes Medical Institute. His work on the olfactory system won him and Linda Buck, a former postdoctoral research scientist in his group, the Nobel Prize in Physiology or Medicine in 2004.

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

<span class="mw-page-title-main">Martin Evans</span> British biologist

Sir Martin John EvansFLSW is an English biologist who, with Matthew Kaufman, was the first to culture mice embryonic stem cells and cultivate them in a laboratory in 1981. He is also known, along with Mario Capecchi and Oliver Smithies, for his work in the development of the knockout mouse and the related technology of gene targeting, a method of using embryonic stem cells to create specific gene modifications in mice. In 2007, the three shared the Nobel Prize in Physiology or Medicine in recognition of their discovery and contribution to the efforts to develop new treatments for illnesses in humans.

<span class="mw-page-title-main">Oliver Smithies</span> British-American geneticist (1925–2017)

Oliver Smithies was a British-American geneticist and physical biochemist. He is known for introducing starch as a medium for gel electrophoresis in 1955, and for the discovery, simultaneously with Mario Capecchi and Martin Evans, of the technique of homologous recombination of transgenic DNA with genomic DNA, a much more reliable method of altering animal genomes than previously used, and the technique behind gene targeting and knockout mice. He received the Nobel Prize in Physiology or Medicine in 2007 for his genetics work.

<span class="mw-page-title-main">Rudolf Jaenisch</span> German biologist

Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.

<span class="mw-page-title-main">Carol W. Greider</span> American molecular biologist and Nobel laureate

Carolyn Widney Greider is an American molecular biologist and Nobel laureate. She joined the University of California, Santa Cruz as a Distinguished Professor in the department of molecular, cell, and developmental biology in October 2020.

<span class="mw-page-title-main">Gene targeting</span> Genetic technique that uses homologous recombination to change an endogenous gene

Gene targeting is a biotechnological tool used to change the DNA sequence of an organism. It is based on the natural DNA-repair mechanism of Homology Directed Repair (HDR), including Homologous Recombination. Gene targeting can be used to make a range of sizes of DNA edits, from larger DNA edits such as inserting entire new genes into an organism, through to much smaller changes to the existing DNA such as a single base-pair change. Gene targeting relies on the presence of a repair template to introduce the user-defined edits to the DNA. The user will design the repair template to contain the desired edit, flanked by DNA sequence corresponding (homologous) to the region of DNA that the user wants to edit; hence the edit is targeted to a particular genomic region. In this way Gene Targeting is distinct from natural homology-directed repair, during which the ‘natural’ DNA repair template of the sister chromatid is used to repair broken DNA. The alteration of DNA sequence in an organism can be useful in both a research context – for example to understand the biological role of a gene – and in biotechnology, for example to alter the traits of an organism.

Conditional gene knockout is a technique used to eliminate a specific gene in a certain tissue, such as the liver. This technique is useful to study the role of individual genes in living organisms. It differs from traditional gene knockout because it targets specific genes at specific times rather than being deleted from beginning of life. Using the conditional gene knockout technique eliminates many of the side effects from traditional gene knockout. In traditional gene knockout, embryonic death from a gene mutation can occur, and this prevents scientists from studying the gene in adults. Some tissues cannot be studied properly in isolation, so the gene must be inactive in a certain tissue while remaining active in others. With this technology, scientists are able to knockout genes at a specific stage in development and study how the knockout of a gene in one tissue affects the same gene in other tissues.

<span class="mw-page-title-main">Lexicon Pharmaceuticals</span>

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands. The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets. Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs. Lexicon is pursuing drug targets in five therapeutic areas including oncology, gastroenterology, immunology, metabolism, and ophthalmology.

<span class="mw-page-title-main">Ralph L. Brinster</span> American geneticist

Ralph Lawrence Brinster is an American geneticist, National Medal of Science laureate, and Richard King Mellon Professor of Reproductive Physiology at the School of Veterinary Medicine, University of Pennsylvania.

<span class="mw-page-title-main">Jack W. Szostak</span> American biologist

Jack William Szostak is a Canadian American biologist of Polish British descent, Nobel Prize laureate, University Professor at the University of Chicago, former Professor of Genetics at Harvard Medical School, and Alexander Rich Distinguished Investigator at Massachusetts General Hospital, Boston. Szostak has made significant contributions to the field of genetics. His achievement helped scientists to map the location of genes in mammals and to develop techniques for manipulating genes. His research findings in this area are also instrumental to the Human Genome Project. He was awarded the 2009 Nobel Prize for Physiology or Medicine, along with Elizabeth Blackburn and Carol W. Greider, for the discovery of how chromosomes are protected by telomeres.

In molecular cloning and biology, a gene knock-in refers to a genetic engineering method that involves the one-for-one substitution of DNA sequence information in a genetic locus or the insertion of sequence information not found within the locus. Typically, this is done in mice since the technology for this process is more refined and there is a high degree of shared sequence complexity between mice and humans. The difference between knock-in technology and traditional transgenic techniques is that a knock-in involves a gene inserted into a specific locus, and is thus a "targeted" insertion. It is the opposite of gene knockout.

<span class="mw-page-title-main">Victor Ambros</span> American developmental biologist (born 1953)

Victor R. Ambros is an American developmental biologist and Nobel Laureate who discovered the first known microRNA (miRNA). He is a professor at the University of Massachusetts Medical School. He completed both his undergraduate and doctoral studies at the Massachusetts Institute of Technology. Ambros received the Nobel Prize in Physiology or Medicine in 2024 for his research on microRNA.

<span class="mw-page-title-main">Genetically modified mouse</span> Mouse with altered genomes

A genetically modified mouse, genetically engineered mouse model (GEMM) or transgenic mouse is a mouse that has had its genome altered through the use of genetic engineering techniques. Genetically modified mice are commonly used for research or as animal models of human diseases and are also used for research on genes. Together with patient-derived xenografts (PDXs), GEMMs are the most common in vivo models in cancer research. Both approaches are considered complementary and may be used to recapitulate different aspects of disease. GEMMs are also of great interest for drug development, as they facilitate target validation and the study of response, resistance, toxicity and pharmacodynamics.

<span class="mw-page-title-main">Adrian Bird</span> British geneticist and professor

Sir Adrian Peter Bird is a British geneticist and Buchanan Professor of Genetics at the University of Edinburgh. Bird has spent much of his academic career in Edinburgh, from receiving his PhD in 1970 to working at the MRC Mammalian Genome Unit and later serving as director of the Wellcome Trust Centre for Cell Biology. His research focuses on understanding DNA methylation and CpG islands, and their role in diseases such as Rett syndrome.

<span class="mw-page-title-main">University of Utah School of Medicine</span> Medical school of the University of Utah

The University of Utah School of Medicine is located on the upper campus of the University of Utah in Salt Lake City, Utah. It was founded in 1905 and is currently the only MD-granting medical school in the state of Utah.

A knockout mouse, or knock-out mouse, is a genetically modified mouse in which researchers have inactivated, or "knocked out", an existing gene by replacing it or disrupting it with an artificial piece of DNA. They are important animal models for studying the role of genes which have been sequenced but whose functions have not been determined. By causing a specific gene to be inactive in the mouse, and observing any differences from normal behaviour or physiology, researchers can infer its probable function.

<span class="mw-page-title-main">Tasuku Honjo</span> Japanese immunologist and Nobel laureate (born 1942)

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines: IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.

Nobuyo N. Maeda is a Japanese geneticist and medical researcher, who works on complex human diseases including atherosclerosis, diabetes and high blood pressure, and is particularly known for creating the first mouse model for atherosclerosis. Maeda has worked in the United States since 1978; as of 2017, she is the Robert H. Wagner Distinguished Professor at the University of North Carolina at Chapel Hill.

References

  1. ↑ Skipper, Magda (2005). "An Interview With Mario Capecchi". Nature Reviews Genetics. 6 (6): 434. doi: 10.1038/nrg1647 . ISSN   1471-0056. PMID   15934189. S2CID   31781543.
  2. ↑ Thomas, K. R.; Capecchi, M. R. (1987). "Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells". Cell. 51 (3): 503–512. doi:10.1016/0092-8674(87)90646-5. PMID   2822260. S2CID   31961262.
  3. ↑ Mansour, S. L.; Thomas, K. R.; Capecchi, M. R. (1988). "Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes". Nature. 336 (6197): 348–352. Bibcode:1988Natur.336..348M. doi:10.1038/336348a0. PMID   3194019. S2CID   2997260.
  4. ↑ Capecchi, M. R. (1980). "High efficiency transformation by direct microinjection of DNA into cultured mammalian cells". Cell. 22 (2 Pt 2): 479–488. doi:10.1016/0092-8674(80)90358-x. PMID   6256082. S2CID   2189404.
  5. ↑ Chisaka, O.; Capecchi, M. R. (1991). "Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5". Nature. 350 (6318): 473–479. Bibcode:1991Natur.350..473C. doi:10.1038/350473a0. PMID   1673020. S2CID   972118.
  6. ↑ Thomas, K. R.; Folger, K. R.; Capecchi, M. R. (1986). "High frequency targeting of genes to specific sites in the mammalian genome". Cell. 44 (3): 419–428. doi:10.1016/0092-8674(86)90463-0. PMID   3002636. S2CID   30570106.
  7. 1 2 "The Nobel Prize in Physiology or Medicine 2007". Nobelprize.org. Retrieved 2007-10-08.
  8. ↑ Mario Capecchi publications indexed by Microsoft Academic
  9. ↑ Kain, K. (2008). "The first transgenic mice: An interview with Mario Capecchi". Disease Models and Mechanisms. 1 (4–5): 197–201. doi:10.1242/dmm.001966. PMC   2590805 . PMID   19093023.
  10. ↑ Cohen-Tannoudji, M. (2007). "Prix Nobel de Médecine 2007". Médecine/Sciences. 23 (12): 1159–1161. doi: 10.1051/medsci/200723121159 . PMID   18154719.
  11. ↑ Capecchi, M. (2005). "An Interview with". Nature Reviews Genetics. 6 (6): 434. doi: 10.1038/nrg1647 . PMID   15934189. S2CID   31781543.
  12. ↑ Dennis, C. (2004). "Mario Capecchi: From rags to research". Nature. 430 (6995): 10–11. Bibcode:2004Natur.430...10D. doi: 10.1038/430010a . PMID   15229575. S2CID   4347862.
  13. ↑ Lois M. Collins (2007-10-08). "U. scientist Capecchi wins Nobel Prize". Deseret Morning News. Archived from the original on February 20, 2009.
  14. ↑ Troy Goodman (2001-09-16). "U. scientist Mario Cappechi scores a 'knockout'". Salt Lake Tribune . Retrieved 2007-10-08.
  15. 1 2 Susan Sample (2007). "Scientist Profile: Mario Capecchi". University of Utah. Archived from the original on 2007-10-11.
  16. ↑ "The Nobel Prize in Physiology or Medicine 2007". NobelPrize.org. Retrieved 20 February 2022.
  17. ↑ Hont G (December 2007). "Från gatubarn till Nobelpristagare. Mario Capecchis liv--en askungesaga" [From street child to Nobel Prize winner. Mario Capecchi's life--a Cinderella story]. Läkartidningen (in Swedish). 104 (51–52): 3905–3907. PMID   18232538.
  18. ↑ "Nobelist's tales of wartime have inconsistencies". Deseret News. Associated Press. 6 November 2007. Retrieved 20 February 2022.
  19. ↑ American Philosophical Society. "Edward G. Ramberg Papers". American Philosophical Society.
  20. ↑ "Obituaries". The Washington Post. Retrieved 2022-06-11.
  21. ↑ Andrew Gumbel (2007-10-09). "Mario Capecchi: The man who changed our world". Belfast Telegraph.
  22. ↑ Arkajit Dey (2007-10-16). "Two Nobel Prize Winners MIT-Affiliated". The Tech .
  23. ↑ Capecchi, Mario (1967). On the Mechanism of Suppression and Polypeptide Chain Initiation (PhD thesis). Harvard University. ProQuest   302261581.
  24. ↑ "Distinguished Lecture Series". Duke University. Archived from the original on 2007-09-08.
  25. ↑ "MBG Annual Racker Lecture". Cornell University.
  26. ↑ Peter Popham (2007-10-18). "Reunion beckons for Nobel winner and his long lost step-sister". Belfast Telegraph.
  27. ↑ "'Looking at the pictures, it was obviously my sister,' Capecchi said, noting her resemblance to their mother." "Nobel Winner Reunited With Sister Lost in WWII". ABC News. Associated Press. 2008-06-06.
  28. ↑ University of Utah, Transgenic Mice
  29. ↑ "2001 Albert Lasker Award for Basic Medical Research". Lasker Foundation. Archived from the original on 2007-09-30. Retrieved 2007-10-01.
  30. ↑ "The President's National Medal of Science: Recipient Details | NSF - National Science Foundation". www.nsf.gov.
  31. ↑ "Past Winners". www.brandeis.edu.
  32. ↑ "UCSF Medal". Office of the Chancellor. Retrieved 1 July 2020.
  33. ↑ "Program and Abstracts of the 14th Transgenic Technology Meeting (TT2017): Snowbird Resort, Salt Lake City, Utah, USA, 1–4 October 2017". Transgenic Research. 26 (S1): 1–45. 2017-09-01. doi:10.1007/s11248-017-0033-2. ISSN   0962-8819. PMID   28864935. S2CID   32962450.
  34. ↑ "Yale awards nine honorary degrees". YaleNews. 2024-05-20. Retrieved 2024-05-21.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.